Lise Rochaix

1.7k total citations
47 papers, 553 citations indexed

About

Lise Rochaix is a scholar working on Economics and Econometrics, General Health Professions and Sociology and Political Science. According to data from OpenAlex, Lise Rochaix has authored 47 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Economics and Econometrics, 20 papers in General Health Professions and 8 papers in Sociology and Political Science. Recurrent topics in Lise Rochaix's work include Healthcare Policy and Management (15 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Pharmaceutical Economics and Policy (12 papers). Lise Rochaix is often cited by papers focused on Healthcare Policy and Management (15 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Pharmaceutical Economics and Policy (12 papers). Lise Rochaix collaborates with scholars based in France, United Kingdom and Germany. Lise Rochaix's co-authors include Peter T. Sawicki, Ruth Lopert, Kalipso Chalkidou, Mona Nasser, Sean Tunis, Sandy Tubeuf, Stéphane Jacobzone, David Wilsford, Rosella Levaggi and Marlène Guillon and has published in prestigious journals such as The Lancet, Social Science & Medicine and International Journal of Environmental Research and Public Health.

In The Last Decade

Lise Rochaix

40 papers receiving 487 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lise Rochaix 324 242 50 50 44 47 553
Martina Garau 394 1.2× 107 0.4× 19 0.4× 32 0.6× 68 1.5× 30 516
Christoph Sowada 222 0.7× 296 1.2× 43 0.9× 10 0.2× 43 1.0× 47 542
Emily Walkom 258 0.8× 165 0.7× 38 0.8× 75 1.5× 32 0.7× 19 578
Cristina Mariano Ruas 156 0.5× 123 0.5× 138 2.8× 9 0.2× 49 1.1× 65 589
Bernarda Zamora 213 0.7× 115 0.5× 25 0.5× 8 0.2× 38 0.9× 36 358
Timothy Stoltzfus Jost 324 1.0× 302 1.2× 35 0.7× 25 0.5× 27 0.6× 127 563
Seth Richards‐Shubik 117 0.4× 184 0.8× 30 0.6× 43 0.9× 12 0.3× 32 384
Michelle McIsaac 77 0.2× 178 0.7× 76 1.5× 9 0.2× 50 1.1× 11 502
Annika Herr 303 0.9× 210 0.9× 32 0.6× 17 0.3× 15 0.3× 29 486
Mehtap Tatar 147 0.5× 217 0.9× 64 1.3× 5 0.1× 114 2.6× 41 475

Countries citing papers authored by Lise Rochaix

Since Specialization
Citations

This map shows the geographic impact of Lise Rochaix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Rochaix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Rochaix more than expected).

Fields of papers citing papers by Lise Rochaix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Rochaix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Rochaix. The network helps show where Lise Rochaix may publish in the future.

Co-authorship network of co-authors of Lise Rochaix

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Rochaix. A scholar is included among the top collaborators of Lise Rochaix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Rochaix. Lise Rochaix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marsaudon, Antoine, et al.. (2024). Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data. Value in Health. 27(10). 1408–1416.
2.
Pillebout, Évangéline, Isabelle Durand‐Zaleski, Lionel Perrier, et al.. (2022). Multicentre, randomised, economic evaluation of a web-based interactive education platform, simple or enhanced, for patients with end-stage renal disease: the PIC-R trial protocol. BMJ Open. 12(12). e062613–e062613.
3.
Fournier, Sandra, Lise Rochaix, Gabriel Birgand, et al.. (2022). Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study. Antimicrobial Resistance and Infection Control. 11(1). 117–117. 7 indexed citations
4.
5.
Barrenho, Eliana, et al.. (2022). Inequities in cancer drug development in terms of unmet medical need. Social Science & Medicine. 302. 114953–114953. 4 indexed citations
6.
Rochaix, Lise, et al.. (2021). Evaluating the Impact of Intensive Case Management for Severe Vocational Injuries on Work Incapacity and Costs. Journal of Occupational Rehabilitation. 31(4). 807–821.
7.
Rochaix, Lise, et al.. (2021). Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List. Health Policy. 125(7). 923–929. 1 indexed citations
8.
Naci, Huseyin, Maximilian Salcher‐Konrad, Aaron S. Kesselheim, et al.. (2020). Generating comparative evidence on new drugs and devices before approval. The Lancet. 395(10228). 986–997. 52 indexed citations
9.
Ghardallou, M. El, Pierre Taupin, Fabien Touzot, et al.. (2019). Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation. Human Gene Therapy. 30(6). 753–761. 39 indexed citations
10.
Guillon, Marlène, et al.. (2018). COST-EFFECTIVENESS OF INTERVENTIONS BASED ON PHYSICAL ACTIVITY IN THE TREATMENT OF CHRONIC CONDITIONS: A SYSTEMATIC LITERATURE REVIEW. International Journal of Technology Assessment in Health Care. 34(5). 481–497. 21 indexed citations
11.
Rochaix, Lise, et al.. (2018). Early Access Schemes and Pricing Strategies: A Case Study on Temporary Authorization for Use in France from 1994 to 2016. Revue française des affaires sociales. 69–89. 3 indexed citations
12.
Dourgnon, Paul, et al.. (2017). Accurate Representation Of Patients’ Opinions For Decision-Making: Are Online Health Communities Good Candidates?. Value in Health. 20(9). A760–A761. 10 indexed citations
13.
Josselin, Jean‐Michel, et al.. (2014). HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes. PharmacoEconomics. 32(9). 825–839. 4 indexed citations
14.
Rouëssé, Jacques, G Bouvenot, Lise Rochaix, et al.. (2011). Mise au point sur la prescription des molécules oné- reuses en cancérologie. Bulletin de l Académie Nationale de Médecine. 195(3). 699–727. 2 indexed citations
15.
Rochaix, Lise & Sandy Tubeuf. (2009). Equity Measurement in Health. Revue économique. 60(2). 325–344. 1 indexed citations
16.
Chalkidou, Kalipso, Sean Tunis, Ruth Lopert, et al.. (2009). Comparative Effectiveness Research and Evidence‐Based Health Policy: Experience from Four Countries. Milbank Quarterly. 87(2). 339–367. 99 indexed citations
17.
Rochaix, Lise, et al.. (2005). Revisiting physicians' financial incentives in Quebec: a panel system approach. Health Economics. 15(1). 49–64. 18 indexed citations
18.
Rochaix, Lise. (2004). Concurrence et assurance santé. Revue d économie politique. Vol. 114(5). 575–576. 1 indexed citations
19.
Paraponaris, Alain, Pierre Verger, P. Villani, et al.. (2004). Delivering generics without regulatory incentives?. Health Policy. 70(1). 23–32. 38 indexed citations
20.
Rochaix, Lise. (1993). Financial incentives for physicians: The Quebec experience. Health Economics. 2(2). 163–176. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Garau Breakdown of academic impact, for papers by Christoph Sowada Breakdown of academic impact, for papers by Emily Walkom Breakdown of academic impact, for papers by Cristina Mariano Ruas Breakdown of academic impact, for papers by Bernarda Zamora Breakdown of academic impact, for papers by Timothy Stoltzfus Jost Breakdown of academic impact, for papers by Seth Richards‐Shubik Breakdown of academic impact, for papers by Michelle McIsaac Breakdown of academic impact, for papers by Annika Herr Breakdown of academic impact, for papers by Mehtap Tatar
Rankless by CCL
2026